Plain-English translation of NCT06566482 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
Phase 4 โ The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
This trial tested a new pain-relief approach using dexmedetomidine-esketamine for patients undergoing surgery who are at risk of obstructive sleep apnea (a condition where breathing stops and starts during sleep). Half of the participants received the new medication combination through a pump they could control themselves after surgery, while the other half received standard pain medication. The goal was to see if this new treatment could reduce pain while improving sleep quality and breathing safety after surgery.
People with sleep apnea are especially vulnerable after surgery because pain medications and remaining anesthesia can suppress breathing and worsen sleep problems. This trial aimed to find a safer pain-relief option that would not only reduce pain but also promote better, healthier sleep during recovery.
Participants underwent scheduled minimally invasive surgery under general anesthesia as planned. After surgery, they received pain medication through a pump they could control themselves by pressing a button when they needed relief, for 24 to 48 hours after surgery. Half received the new medication combination, while half received standard medication. The trial examined how well they slept, how much pain they experienced, and how safely they breathed during their recovery period.
AI-generated summary from trial data ยท Sep 19, 2026 ยท Not medical advice
China